Steatotic liver disease (SLD) displays a dynamic and complex disease phenotype.
Consequently, the metabolic dysfunction-associated steatotic liver disease …

Type 2 Diabetes Mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD) are part of
metabolic syndrome and share multiple causal associations. Both conditions have an …

The prevalence of juvenile obesity is increasing, reaching epidemic proportions, presenting
a link not only to NAFLD (non-alcoholic fatty liver disease) but to abnormal lipid profiles and …

Objective To investigate the association between non-alcoholic fatty liver disease (NAFLD)
and liver enzymes with the incidence of microvascular complications (neuropathy …

Nonalcoholic fatty liver disease (NAFLD), recently renamed metabolic dysfunction-
associated steatotic liver disease (MASLD) affects~ 70% of patients with type 2 diabetes …

Introduction Nonalcoholic fatty liver disease (NAFLD) is considered a multisystem disease,
as it is bidirectionally linked to other cardiometabolic disorders, such as type 2 diabetes …

Background Metabolic-associated fatty liver disease (MAFLD), formerly known as non-
alcoholic fatty liver disease, is the leading cause of liver disease that can ultimately lead to …

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease in the
world and represents a clinical-histopathologic entity where the steatosis component may …

Aim Nonalcoholic fatty liver disease (NAFLD) is a silent epidemy that has become the most
common chronic liver disease worldwide. Nonalcoholic steatohepatitis (NASH) is an …

Over the past 100 years, cardiovascular disease (CVD) has become a leading cause of
mortality and morbidity in developed countries, and similar trends have occurred for chronic …